STATE System Medicaid Coverage of Tobacco Cessation Treatments Fact Sheet
Smoking is the leading preventable cause of premature death in the United States, resulting in about 480,000 deaths each year.1 More than 16 million Americans suffer from a disease caused by smoking.1 Adults enrolled in Medicaid smoke cigarettes at a rate more than twice as high as that of privately insured adults (23.9% vs. 10.5%, respectively).2 Nationally, Medicaid spends about $40 billion on health care for smoking-related diseases annually—more than 15% of total Medicaid spending.1 Smoking cessation improves health status, enhances quality of life, reduces the risk of premature death, and can add as much as a decade to life expectancy.3 Smoking cessation also reduces the substantial financial burden that smoking places on smokers, health care systems, and society.3
The traditional Medicaid population is by definition low-income, and therefore less able to pay out-of-pocket for tobacco cessation treatments than people with higher incomes. Medicaid enrollees are also less likely than higher-income people to be able to successfully navigate the system to overcome barriers to accessing cessation treatments.4
While most smokers want to quit and many smokers try to quit each year, quitting smoking is difficult. Most smokers try to quit smoking several times before succeeding. One reason for this is that few smokers use cessation treatments that have been shown to increase quit rates when trying to quit.3,5 In 2015, 69.2% of adult smokers enrolled in Medicaid wanted to stop smoking, 56.3% tried to do so in the past year, but only 5.9% succeeded in quitting.5 Only 34.5% of smokers enrolled in Medicaid who tried to quit had used evidence-based counseling or medications, or both.5
Smoking cessation medications approved by the U.S. Food and Drug Administration and behavioral counseling are cost-effective cessation strategies. Cessation medications approved by the U.S. Food and Drug Administration and behavioral counseling increase the likelihood of successfully quitting smoking, particularly when used in combination.3 Using combinations of nicotine replacement therapies can further increase the likelihood of quitting.3 Insurance coverage for smoking cessation treatment that is comprehensive, barrier-free, and widely promoted increases the use of these treatment services, leads to higher rates of successful quitting, and is cost-effective.3 In particular, more comprehensive state Medicaid coverage for cessation treatments appears to be associated with increased quit rates among smokers enrolled in Medicaid.6 Additionally, making cessation benefits more accessible to smokers on Medicaid by removing barriers to accessing cessation treatments such as cost-sharing and prior authorization would also be expected to increase the use of cessation treatments and successful quit attempts.3 Cost-sharing means any requirement that Medicaid enrollees pay for the treatment, including co-pays, deductibles, and coinsurance.
Evidence suggests that states could reduce smoking rates, smoking-related disease, and health care costs among Medicaid enrollees by providing Medicaid coverage for all evidence-based cessation treatments, removing all barriers to accessing these treatments, promoting the coverage, and monitoring its use.3,6,7,8,9
Traditional Medicaid vs. Medicaid Expansion
The Affordable Care Act establishes new income-based eligibility standards for Medicaid for states implementing Medicaid expansion. Plans offered to Medicaid enrollees who are newly eligible under this expansion (“expansion plans”) have different requirements for coverage than plans offered to those already enrolled in or eligible for Medicaid before 2014 (“traditional Medicaid”). The sections below address these different requirements.
Coverage for pregnant women
The Affordable Care Act has required Medicaid programs to cover tobacco cessation counseling and medications for pregnant women since October 2010. This requirement prohibits cost sharing for covered counseling and medications. This provision has resulted in increases in state Medicaid coverage of cessation counseling and medications for pregnant women.10
Coverage of tobacco cessation counseling
The Affordable Care Act does not require state Medicaid programs to cover individual, group, or telephone cessation counseling for non-pregnant adult Medicaid enrollees. However, states can choose to cover these treatments. Coverage of individual counseling is typically provided through payments to health care providers. Group counseling can be covered in a variety of ways, such as through a separate wellness program vendor or by reimbursing health care providers for group sessions. Telephone counseling can be provided to Medicaid enrollees through state quitlines, and states can now receive federal administrative matching funds for this counseling. Medicaid expansion plans are subject to a different set of Affordable Care Act requirements, which require these plans to cover evidence-based preventive services, including tobacco cessation, with no cost-sharing.
Coverage of tobacco cessation medications
Beginning in January 2014, the Affordable Care Act prohibits state Medicaid programs from excluding any of the seven FDA-approved tobacco cessation medications from traditional Medicaid coverage. However, the provision does not require state Medicaid programs to remove barriers to accessing these medications. Medicaid expansion plans are subject to a different set of requirements. The Affordable Care Act requires these plans to cover evidence-based preventive services, including tobacco cessation, with no cost-sharing. A recent study found that only approximately 10% of Medicaid enrollees who smoked received a prescription for a tobacco cessation medication in 2013, with wide variation in use of cessation medications across states.11
All state Medicaid programs cover some cessation treatments for all state Medicaid enrollees. However, only 18 states (California, Colorado, Connecticut, Illinois, Kansas, Kentucky, Maine, Massachusetts, Missouri, New York, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, South Carolina, Virginia, and Wisconsin) have comprehensive Medicaid coverage as of September 30, 2022. Kentucky, Missouri, and Wisconsin are the only states without any barriers in place to accessing any of these treatments.
|State||Individual Counseling||Group Counseling||Nicotine Patch||Nicotine Gum||Nicotine Lozenge||Nicotine Nasal Spray||Nicotine Inhaler||Bupropion||Varenicline||Comprehensive Coverage|
|Delaware||Not Available||Not Available||Yes||Yes||Yes||Varies||Varies||Yes||Varies||No|
|District of Columbia||Yes||No||Yes||Yes||Yes||Varies||Varies||Yes||Yes||No|
“Yes” means that the treatment is covered for all plans, including fee-for-service and managed care plans, if applicable. “No” means that the treatment is not covered.
“Varies” means that the coverage of treatment under both fee-for-service and managed care plans varies by plan or pregnancy status. Telephone counseling is not included because it is available free to callers to state quitlines (including Medicaid enrollees) in all 50 states and the District of Columbia through the national quitline portal 1-800-QUIT-NOW. Coverage reported here is traditional Medicaid coverage, not coverage in Medicaid expansion plans.
1. US Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
2. Creamer MR, Wang TW, Babb S, Cullen KA, Day H, Willis G, Jamal A, Neff L. Tobacco product use and cessation indicators among adults—United States, 2018. [PDF – 219 KB] MMWR Morb Mortal Wkly Rep 2019;68:1013-1019
3. U.S. Department of Health and Human Services. Smoking Cessation. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2020.
4. Saunders MR, Alexander C. Turning and churning: loss of health insurance among adults in Medicaid. J Gen Intern Med. 2009;24:133–34.
5. Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting Smoking Among Adults—United States, 2000–2015. MMWR Morb Mortal Wkly Rep 2017;65:1457–1464.
6. Kostova D, Xu X, Babb S, McMenamin SB, King BA. Does state Medicaid coverage of smoking cessation treatments affect quitting? Health Serv Res 2018; 53(6):4725-46.
7. Land T, Warner D, Paskowsky M, et al. Medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in smoking prevalence. PLoS ONE. 2010;5:e9770.
8. Land T, Rigotti NA, Levy DE, et al. A longitudinal study of Medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular diseases. PLoS Med 2010;7:e1000375.
9. Richard P, West K, Ku L. The return on investment of a Medicaid tobacco cessation program in Massachusetts. PLoS One. 2012;7:e29665.
10. McMenamin SB, Halpin HA, Ganiats TG. Medicaid coverage of tobacco-dependence treatment for pregnant women: impact of the Affordable Care Act. Am J Prev Med. 2012;43:e27–9.
11. Ku L, Bruen BK, Steinmetz E, Bysshe T. Medicaid tobacco cessation: big gaps remain in efforts to get smokers to quit. Health Aff (Millwood) 2016;35:62–70.
DISCLAIMER: The STATE System contains data synthesized from state-level statutory laws. It does not contain state-level regulations; measures implemented by counties, cities, or other localities; opinions of Attorneys General; or relevant case law decisions for tobacco control topics other than preemption; all of which may vary significantly from the laws reported in the database, fact sheets, and publications.